Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$10.91
-0.7%
$11.87
$4.88
$13.14
$1.59B1.051.95 million shs720,393 shs
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$20.00
$19.98
$12.26
$20.57
$843.96M0.74765,906 shs4,300 shs
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
$24.04
$24.02
$8.42
$24.25
$1.76B3.022.70 million shsN/A
Luminex Co. stock logo
LMNX
Luminex
$36.99
$36.90
$20.61
$41.69
$1.75B0.56873,093 shsN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$6.80
+2.1%
$6.51
$5.47
$10.14
$1.00B1.76650,339 shs1.12 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
0.00%+0.05%-0.63%+7.96%-2.31%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00%0.00%0.00%0.00%0.00%
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
0.00%0.00%0.00%0.00%0.00%
Luminex Co. stock logo
LMNX
Luminex
0.00%0.00%0.00%0.00%0.00%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.00%+5.97%+10.26%-1.62%-6.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.3564 of 5 stars
3.41.00.03.33.84.20.6
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/AN/AN/AN/A
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
N/AN/AN/AN/AN/AN/AN/AN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.814 of 5 stars
3.52.00.00.03.63.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.89
Moderate Buy$17.8963.97% Upside
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00
N/AN/AN/A
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
0.00
N/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
0.00
N/AN/AN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.00
Buy$12.5083.82% Upside

Current Analyst Ratings Breakdown

Latest GNMK, LMNX, CSII, ATEC, and MDXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$18.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$13.00 ➝ $15.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
4/14/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$642.27M2.48N/AN/A($0.10) per share-109.10
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$239.84M3.52N/AN/A$6.12 per share3.27
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
$88.02M19.96N/AN/A$0.21 per share114.48
Luminex Co. stock logo
LMNX
Luminex
$417.40M4.19$1.12 per share32.98$11.13 per share3.32
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$348.88M2.88$0.34 per share20.10$1.31 per share5.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$162.12M-$1.15N/AN/AN/A-25.77%-1,657.19%-21.53%7/30/2025 (Estimated)
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/A
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
-$47.35M-$0.82N/AN/AN/A-16.95%-39.36%-13.02%N/A
Luminex Co. stock logo
LMNX
Luminex
$15.17M$0.3272.5330.83N/A5.39%4.66%2.91%N/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$42.42M$0.2725.1921.25N/A11.40%22.70%16.77%7/30/2025 (Estimated)

Latest GNMK, LMNX, CSII, ATEC, and MDXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.06N/AN/AN/A$178.85 millionN/A
7/30/2025Q2 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06N/AN/AN/A$90.79 millionN/A
5/1/2025Q1 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.12-$0.35-$0.23-$0.35$167.57 million$169.18 million
4/30/2025Q1 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06$0.06N/A$0.05$86.32 million$88.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/A
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
N/AN/AN/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
$0.401.08%N/A125.00%N/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/A
2.75
1.67
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.08
6.04
4.92
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
0.75
4.33
3.84
Luminex Co. stock logo
LMNX
Luminex
0.52
8.37
6.08
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.09
4.70
4.13

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
86.61%
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
96.94%
Luminex Co. stock logo
LMNX
Luminex
87.76%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
79.15%

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
20.90%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
3.80%
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
3.25%
Luminex Co. stock logo
LMNX
Luminex
6.60%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
1.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700146.17 million112.85 millionOptionable
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
78042.20 million40.59 millionOptionable
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
61873.09 millionN/AOptionable
Luminex Co. stock logo
LMNX
Luminex
1,32547.31 millionN/AOptionable
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
870147.70 million145.19 millionOptionable

Recent News About These Companies

MDXG MiMedx Group, Inc. - Seeking Alpha
Director Of MiMedx Group Makes $185K Buy
MIMEDX to Participate in Upcoming Investor Conferences
Zooming In On MiMedx Group's Earnings
MiMedx (MDXG) Q1 Earnings Match Estimates
MiMedx price target lowered to $15 from $16 at Mizuho

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alphatec stock logo

Alphatec NASDAQ:ATEC

$10.91 -0.08 (-0.73%)
Closing price 04:00 PM Eastern
Extended Trading
$10.82 -0.09 (-0.82%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Cardiovascular Systems stock logo

Cardiovascular Systems NASDAQ:CSII

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

GenMark Diagnostics stock logo

GenMark Diagnostics NASDAQ:GNMK

GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company also offers Blood Culture Identification Gram-Positive and Negative panel, Blood Culture Identification Fungal Pathogen panel, and ePlex Gastrointestinal Pathogen Panel. In addition, it provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. Further, the company offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, thrombophilia risk test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test and eSensor SARS-CoV-2 Test. GenMark Diagnostics, Inc. sells its products through direct sales and technically specialized service organization in the United States, Europe, and internationally. The company was incorporated in 2010 and is headquartered in Carlsbad, California.

Luminex stock logo

Luminex NASDAQ:LMNX

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

MiMedx Group stock logo

MiMedx Group NASDAQ:MDXG

$6.80 +0.14 (+2.10%)
Closing price 04:00 PM Eastern
Extended Trading
$5.38 -1.42 (-20.81%)
As of 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.